Valentina Ivanova Selected Research

Multiple Myeloma

1/2016	Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma.
10/2015	Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.
10/2015	Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone.
10/2013	Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentina Ivanova Research Topics

Disease

4	Multiple Myeloma 01/2016 - 10/2013
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 05/2004 - 03/2004
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2014
1	Infections 10/2014
1	Disease Progression 10/2013
1	Fatigue 10/2013
1	Pneumonia (Pneumonitis) 10/2013
1	Thrombocytopenia (Thrombopenia) 10/2013
1	Neutropenia 10/2013
1	Pain (Aches) 10/2013

Drug/Important Bio-Agent (IBA)

4	pomalidomideIBA 01/2016 - 10/2013
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 10/2013
3	Bortezomib (Velcade)FDA Link 01/2016 - 10/2013
3	Lenalidomide (CC 5013)FDA Link 01/2016 - 10/2013
2	4-thiopyridineIBA 05/2004 - 03/2004
1	Rituximab (Mabthera)FDA Link 10/2014
1	calomelIBA 03/2004

Therapy/Procedure

1	Electrodes (Electrode) 03/2004